Pulse 探索 nav.journalClub 辩论趋势研究者期刊

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

首页探索 nav.journalClub 趋势

⌘+K

Open Clinical Trial Data for All? A View from Regulators | Synapse

April 10, 2012PLoS Medicine109 citationsOpen Access

向所有人开放临床试验数据？来自监管机构的视角

HEHans‐Georg EichlerUniversity of Hawaiʻi at Mānoa ÉAÉric AbadieBoston University ABAlasdair BreckenridgeUniversity of Liverpool

Key Points

Key points are not available for this paper at this time.

Abstract

来自 European Medicines Agency 的 Hans-Georg Eichler 及其同事就获取临床试验数据提供了来自监管机构的观点。

问 AI

Like

Bookmark

Share

View Full Paper

问 AI

Like

Bookmark

Share

View Full Paper

Cite This Study

Eichler et al. (Tue,) 研究了这一问题。

synapsesocial.com/papers/6a5cca96fbfab74aebc224af https://doi.org/https://doi.org/10.1371/journal.pmed.1001202

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience2012 · 166 citations
2Transparency and the Food and Drug Administration—A Quantitative Study2012 · 12 citations
3Reinventing discovery: the new era of networked science2012 · 657 citations
4An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase2002 · 61 citations
5The Safety of Tiotropium — The FDA's Conclusions2010 · 113 citations